News

Revised bill on NPs serves as reminder of challenges

BY Antoinette Alexander

After failing to gain enough support in a California Assembly, a revised bill that allows nurse practitioners to operate independently only in a hospital, clinic or other group setting regained some of its momentum and advanced in the assembly.

With the introduction of Senate Bill 941, as well as proposed legislation that is currently pending in several other states, it is clear that lawmakers are increasingly recognizing the vital role that nurse practitioners play. They also are realizing that expanding nurse practitioners’ scope of practice will only become increasingly important as millions of uninsured Americans come into the insurance fold in 2014 due to health reform amid a growing shortage of primary care physicians.

According to a team of researchers in a report titled “Projecting U.S. Primary Care Physician Workforce Needs: 2010-2015,” after incorporating insurance expansion, the United States will require nearly 52,000 additional primary care physicians by 2025.

While it is clear that lawmakers are taking note of the important role that nurse practitioners play in an already strained healthcare system, it is also evident that there’s much more work to be done to overcome resistance.

In its original version, Senate Bill 941 aimed to establish independent practice for NPs, enabling them to perform all tasks and functions consistent with their education and training. It wasn’t until the bill was revised and narrowed — removing a trail to independent practice without physician oversight after more than 6,000 hours of supervised practice — that it advanced in the Assembly.

“…These changes undermine the very heart of the legislation’s original objectives, creating additional, unnecessary regulatory roadblocks just as national healthcare reform is necessitating that the industry streamline care delivery models…” stated The American Association of Nurse Practitioners presidents Angela Golden and Kenneth Miller in a prepared statement.

The reality is that the spotlight remains fixed on scope of practice and how Americans can gain greater access to quality, convenient and cost-effective healthcare services. It is an issue that won’t fade away any time soon.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

NACDS announces winners of Total Store Expo Product Showcase

BY Antoinette Alexander

ARLINGTON, Va. — The National Association of Chain Drug Stores has announced the winners of the 2013 NACDS Total Store Expo Product Showcase.  

The 160 products, ranging from health and beauty to seasonal items, were on display in the “Product Showcase” on the exhibit floor. The Showcase provided increased visibility for suppliers marketing products.  

Evaluated by the retail attendees, winners of this year’s “Product Showcase” are:

Baby Care
              
Company/booth: Fleet Laboratories / Booth 3240
Product: Boudreaux’s Butt Paste

Consumables                       
Company/booth: The Jel Sert Company / Booth 3249
Product: Super C Vitamin Drink Mix

Cosmetics & Fragrances  

Company/booth: Beauty 21 / LA Colors  / LA Girl / Booth 5045
Product: Hot New Nail Products

General Merchandise         
Company/booth: Pet Head Inc. / Booth 5057
Product: Pet Dry Shampoo

Healthcare/OTC      
Company/booth: BrookLands Inc. / Booth 3360
Product: VeraTemp

Home Healthcare    
Company/booth: ChoiceMMed America Co / Booth 4749
Product: Lung Boost Respiratory Trainer

Household Products/Non-Edible Consumables
Company/booth: ShurTech Brands, LLC / Booth 3257
Product: Disney Licensed Duck Tape

Personal Care/HBC  
Company/booth: Wahl Clipper Corp./ Booth 3058
Product: Grooms Man Trimmer

Pharmacy Operations Equipment & Services
Company/booth: AccessaMed, Inc. / Booth 5002
Product: Digital Audio Label

Pharmacy Products
Company/booth: Mylan Inc. / Booth 3426
Product: EpiPen Jr.

Seasonal
Company/booth: IMPLUS Foot Care / Booth 3349
Product: Little Hotties Warmers
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

CareMed selected to distribute Tarceva

BY Alaric DeArment

LAKE SUCCESS, N.Y. — Specialty pharmacy CareMed Pharmaceutical Services has been added to a limited-distribution network for a cancer drug sold by Genentech and Astellas Pharma, the company said.

CareMed said it had been selected to supply the drug, Tarceva (erlotinib). The two drug makers stopped distributing the drug, a once-daily treatment for advanced lung cancer, through retail pharmacies at the beginning of July.

"CareMed is honored to be able to continue supplying our patients with Tarceva," CareMed SVP sales and marketing John Witkowski said. "In 2013, the American Cancer Society estimates 228,000 Americans will be diagnosed with lung cancer, with [non-small cell lung cancer] accounting for 85% of lung cancer cases. Of these, the majority of people diagnosed will already be in an advanced stage of the disease."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?